Physician profile
Yaming Shi
NPI 1275561284
$916.97
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $22.36 · 2021: $371 · 2022: $250.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $567.35 | 2019-2022 | |
| Stryker Corporation | $142.86 | 2022 | |
| Lilly USA, LLC | $93.56 | 2021-2022 | |
| Amarin Pharma, INC. | $23.06 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.72 | 2022 | |
| Redhill Biopharma INC. | $19.50 | 2021 | |
| Alvogen INC | $18.78 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $18.40 | 2019 | |
| Scilex Pharmaceuticals INC. | $13.74 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yaming Shi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.